NCT05881330View on ClinicalTrials.gov

ArtiAid® for Knee Osteoarthritis: A Post-market Study

NACompletedINTERVENTIONAL
Enrollment

59

Participants

Timeline

Start Date

July 1, 2021

Primary Completion Date

September 22, 2022

Study Completion Date

November 25, 2022

Conditions
Hyaluronic Acid
Interventions
DEVICE

ArtiAid Intra-articular Injection

Inject ArtiAid® in the affected joint at weekly interval for 5 weeks.

Trial Locations (1)

33383

Tri-Service General Hospital, Taoyuan

Sponsors
All Listed Sponsors
lead

Maxigen Biotech Inc.

INDUSTRY

NCT05881330 - ArtiAid® for Knee Osteoarthritis: A Post-market Study | Biotech Hunter | Biotech Hunter